您当前所在的位置:首页 > 产品中心 > 产品信息
RRD-251 hydrochloride_分子结构_CAS_72214-67-6)
点击图片或这里关闭

RRD-251 hydrochloride

产品号 R7532 公司名称 Sigma Aldrich
CAS号 72214-67-6 公司网站 http://www.sigmaaldrich.com
分子式 C8H9Cl3N2S 电 话 1-800-521-8956
分子量 271.59446 传 真
纯 度 ≥98% (HPLC) 电子邮件
保 存 desiccated Chembase数据库ID: 154355

产品价格信息

请登录

产品别名

标题
RRD-251 hydrochloride
IUPAC标准名
{[(2,4-dichlorophenyl)methyl]sulfanyl}methanimidamide hydrochloride
IUPAC传统名
[(2,4-dichlorophenyl)methyl]sulfanylmethanimidamide hydrochloride
别名
Rb/Raf-1 disruptor 251 hydrochloride
2-(2,4-Dichlorobenzyl)-2-thiopseudourea hydrochloride
(2,4-Dichlorophenyl)carbamimidothioic acid methyl ester hydrochloride
S-(2,4-Dichlorobenzyl)-isothiouronium hydrochloride

产品登记号

CAS号 72214-67-6
MDL号 MFCD00035047

产品性质

Empirical Formula (Hill Notation) C8H8Cl2N2S· HCl
纯度 ≥98% (HPLC)
外观 white to off-white powder
溶解度 DMSO: >10 mg/mL
溶解度 H2O: >2 mg/mL
GHS危险品标识 GHS07
GHS警示词 Warning
GHS危险声明 H302-H315-H319-H335
欧盟危险性物质标志 有害性(Harmful) 有害性(Harmful) (Xn)
MSDS下载 下载链接
GHS警示性声明 P261
危险公开号 22-36/37/38
安全公开号 26
保存条件 desiccated
保存温度 room temp
德国WGK号 3

产品详细信息

详细说明 (English)
Biochem/physiol Actions
RRD-251 hydrochloride is a reversible, potent, and selective disruptor of Rb/Raf-1 interaction. The retinoblastoma tumor suppressor protein (Rb) controls the G1-S boundary by repressing the transcriptional activity of the E2F family of transcription factors. Raf-1 kinase binds and phosphorylates Rb early in the G1 phase. RRD-251 significantly inhibits angiogenesis and tumor growth in vivo in an Rb-dependent manner. RRD-251 does not inhibit the binding of B-Raf to Rb and Raf-1 to Mek1/2. Also, RRD-251 does not affect the kinase activities associated with cyclin D, cyclin E, or Raf-1.
详细说明 (简体中文)
Biochem/physiol Actions
RRD-251 hydrochloride is a reversible, potent, and selective disruptor of Rb/Raf-1 interaction. The retinoblastoma tumor suppressor protein (Rb) controls the G1-S boundary by repressing the transcriptional activity of the E2F family of transcription factors. Raf-1 kinase binds and phosphorylates Rb early in the G1 phase. RRD-251 significantly inhibits angiogenesis and tumor growth in vivo in an Rb-dependent manner. RRD-251 does not inhibit the binding of B-Raf to Rb and Raf-1 to Mek1/2. Also, RRD-251 does not affect the kinase activities associated with cyclin D, cyclin E, or Raf-1.

参考文献